GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OTCPK:VTRLY) » Definitions » Dividend Payout Ratio

VTRLY (Vitrolife AB) Dividend Payout Ratio : 0.00 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Vitrolife AB Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Vitrolife AB's Dividend Payout Ratio for the months ended in Dec. 2024 was 0.00.

The historical rank and industry rank for Vitrolife AB's Dividend Payout Ratio or its related term are showing as below:

VTRLY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.19   Med: 0.26   Max: 0.27
Current: 0.27


During the past 13 years, the highest Dividend Payout Ratio of Vitrolife AB was 0.27. The lowest was 0.19. And the median was 0.26.

VTRLY's Dividend Payout Ratio is ranked better than
76.11% of 293 companies
in the Medical Devices & Instruments industry
Industry Median: 0.41 vs VTRLY: 0.27

As of today (2025-03-25), the Dividend Yield % of Vitrolife AB is 0.51%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Vitrolife AB was 0.92%. The lowest was 0.14%. And the median was 0.45%.

Vitrolife AB's Dividends per Share for the months ended in Dec. 2024 was $0.00.

During the past 12 months, Vitrolife AB's average Dividends Per Share Growth Rate was 17.60% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 7.70% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Vitrolife AB was 58.70% per year. The lowest was -2.00% per year. And the median was 18.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Vitrolife AB Dividend Payout Ratio Historical Data

The historical data trend for Vitrolife AB's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Dividend Payout Ratio Chart

Vitrolife AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.27 0.27 - 0.27

Vitrolife AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.95 - -

Competitive Comparison of Vitrolife AB's Dividend Payout Ratio

For the Medical Devices subindustry, Vitrolife AB's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's Dividend Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Dividend Payout Ratio falls into.



Vitrolife AB Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Vitrolife AB's Dividend Payout Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2024 )/ EPS without NRI (A: Dec. 2024 )
=0.092/ 0.344
=0.27

Vitrolife AB's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2024 )/ EPS without NRI (Q: Dec. 2024 )
=0/ 0.093
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vitrolife AB (OTCPK:VTRLY) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Vitrolife AB Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.